Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024
Tribe Public announced a webinar event titled 'Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing' featuring Modular Medical's CEO Jeb Besser, scheduled for Monday, November 11, 2024. The event highlights the connection between obesity and diabetes, noting that obesity is linked to 30% to 53% of new diabetes cases in the U.S. annually, according to research published in the Journal of the American Heart Association.
Tribe Public ha annunciato un webinar intitolato 'Personalizzare i trattamenti per la perdita di peso GLP-1: approcci innovativi per una somministrazione personalizzata', con il CEO di Modular Medical, Jeb Besser, in programma per lunedì 11 novembre 2024. L'evento mette in luce il legame tra obesità e diabete, evidenziando che l'obesità è collegata a il 30% al 53% dei nuovi casi di diabete negli Stati Uniti ogni anno, secondo una ricerca pubblicata nel Journal of the American Heart Association.
Tribe Public anunció un evento de seminario web titulado 'Personalizando los tratamientos de pérdida de peso GLP-1: enfoques innovadores para la dosificación personalizada', con el CEO de Modular Medical, Jeb Besser, programado para el lunes 11 de noviembre de 2024. El evento destaca la conexión entre la obesidad y la diabetes, señalando que la obesidad está relacionada con el 30% al 53% de los nuevos casos de diabetes en los EE.UU. anualmente, según una investigación publicada en el Journal of the American Heart Association.
Tribe Public은 'GLP-1 체중 감량 치료 맞춤화: 개인화된 용량을 위한 혁신적인 접근'이라는 제목의 웨비나를 발표했습니다. 이 웨비나는 Modular Medical의 CEO인 Jeb Besser가 진행하며, 2024년 11월 11일 월요일로 예정되어 있습니다. 이 행사에서는 비만과 당뇨병 간의 연관성을 강조하며, 매년 미국에서 발생하는 30%에서 53%의 새로운 당뇨병 사례가 비만과 관련이 있다고 지적했습니다. 이 수치는 미국 심장 협회 저널에 발표된 연구에 근거합니다.
Tribe Public a annoncé un événement webinaire intitulé 'Personnaliser les traitements de perte de poids GLP-1 : approches innovantes pour un dosage personnalisé', avec Jeb Besser, PDG de Modular Medical, prévu pour le lundi 11 novembre 2024. L'événement met en lumière le lien entre l'obésité et le diabète, soulignant que l'obésité est liée à 30 % à 53 % des nouveaux cas de diabète aux États-Unis chaque année, selon une recherche publiée dans le Journal of the American Heart Association.
Tribe Public kündigte ein Webinar mit dem Titel 'GLP-1-Gewichtsreduktionsbehandlungen anpassen: Innovative Ansätze für personalisierte Dosierung' an, das am Montag, den 11. November 2024, mit Jeb Besser, dem CEO von Modular Medical, stattfinden wird. Die Veranstaltung beleuchtet die Verbindung zwischen Fettleibigkeit und Diabetes und weist darauf hin, dass Fettleibigkeit laut einer im Journal of the American Heart Association veröffentlichten Studie mit 30% bis 53% der neuen Diabetesfälle in den USA jährlich verbunden ist.
- None.
- None.
Meet with Modular Medical CEO, Jeb Besser
Obesity is linked to
30% to53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart AssociationAbout half of all patients prescribed a GLP-1 drug for weight loss discontinued after the first 12 weeks, with approximately
30% discontinuing in the first four weeksDiscover Modular Medical's Recently Announced Results from a Successful GLP-1 Proof of Concept Study
SAN DIEGO, CA / ACCESSWIRE / November 8, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing." The event is scheduled to begin at 8:00am pacific/11:00am eastern on Monday, November 11, 2024. To register to join the complimentary event, please visit the Tribe Public LLC at MODDNOV1124.TribePublic.com
Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.
About Modular Medical
Modular Medical, Inc. (NASDAQ:MODD) is a medical device company that will launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and clinical efficacy, thereby making top quality insulin delivery both affordable and simple to learn. The Company's mission is to improve access to the highest standard of glycemic control for people with diabetes, taking it beyond "superusers" and providing diabetes care for the rest of us.
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
ABOUT TRIBE PUBLIC LLC
Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe's complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and members of media. Tribe Members are encouraged to express their interest in speakers they care about and want to learn from at the Tribe Public website via the Tribe's FREE "Wish List" process. Visit Tribe Public's Website to learn more: http://www.tribepublic.com/
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on accesswire.com
FAQ
When is Modular Medical (MODD) hosting the GLP-1 weight loss treatments webinar?
What percentage of new diabetes cases in the US are linked to obesity according to Modular Medical's (MODD) presentation?
Who is presenting at the Modular Medical (MODD) GLP-1 webinar event?
